Magnus Holm Email and Phone Number
Lomma, SE
Magnus Holm's Location
Lomma, Skåne County, Sweden, Sweden
Magnus Holm's Contact Details
Magnus Holm work email
- Valid
- Valid
Magnus Holm personal email
n/a
Magnus Holm phone numbers
About Magnus Holm
Experienced in international and entrepreneurial leadership, business development, management boards, coaching and venture capital I have a track record in funding, developing and introduce-to-market innovative Medical Devices and Digital Health technologies with focus on Electrophysiology, Cardiovascular and Imaging solutions. My background includes evidence-based medicine, market development, product development, clinical application and adoption as well as sales, marketing and scaling organisations within European (EMEA) and global enterprises as well as start-up companies in the medical device and Digital Health industry.I provide the value of an entrepreneurial mindset, solid clinical understanding and experience in Electrophysiology/Interventional/Imaging Cardiovascular fields, as well as broad knowledge and comprehension of technology, business and finances. I combine this to provide value and solutions to medical community while driving ROI for shareholders. My capabilities also includes recruiting/managing/developing people and working in multi-country environments with broad mix of languages, cultures, and religions.
Magnus Holm Work Experience Details
-
Horizon Europe Eic Accelerator And Transition Program JuryEuropean CommissionLomma, Se -
Advisory Board ChairmanChambertech Jul 2024 - PresentLondonområdet, Storbritannien -
Chairman Of The BoardNavari Surgical Ab Feb 2023 - PresentGothenburg, Vastra Gotaland County, Sweden
-
Venture PartnerPeppermint Venture Partners Sep 2012 - PresentEuropeIdentify, assess and strategically decide on novel investment opportunities as well as portfolio companies to help creating new medical device and eHealth Start-ups and supporting young Med Tech companies in developing and commercializing their innovative products, with the aim of improving patient treatment and increasing efficacy and efficiency in hospital care -
Ceo, Entrepreneur In Medical Devices And Digital Health BusinessesCmh Medical Jul 2011 - PresentEurope, Middle East And Africa (Emea)Establishing, funding and strategic expansion of young Medical Device, Life Science or eHealth businesses, creation of new markets for and introduction of new innovative medical or mobile technologies, and establishing high specialist treatments in Interventional Medicine and Interventional Cardiology
-
Board MemberCathvision May 2014 - PresentCopenhagen Area, DenmarkCathVision is developing non-invasive technology to guide therapy for arrhythmia. The company's product visualizes the smallest heart signals. High quality electrophysiology signals are a key component of delivering accurate therapy to complex arrhythmia. -
Horizon Europe Eic Accelerator Program JuryEuropean Commission Dec 2017 - PresentBrussels Area, BelgiumExpert reviewer within the field of Medical Devices and eHealth for the European Commission Executive Agency for Small and Medium-sized Enterprises (EASME) in the context of managing of EU research and innovation programmes.
-
Chairman Of The BoardMedbeat Sweden Feb 2019 - Jun 2023Lund, Sweden
-
Senior ConsultantMd Medical Devices Consulting/Medeuronet Apr 2015 - Jun 2022EuropeMD Medical Devices Consulting SAS provides specialist services to the Medical Devices Industry across Europe. Our international clients benefit from services in Senior Executive Search & Selection and Market Access.MD Medical Devices Consulting SAS consist of a team of Senior Consultants all who have had successful medical devices leadership experience with industry leaders globally or in Europe, being supported by an international back-up team in Paris.
-
Board MemberMiracor Medical Systems Sa Oct 2016 - Aug 2021Belgium
-
Lead Electrophysiology ApplicationsSpectrum Dynamics Medical Dec 2015 - Nov 2019GlobalGlobal lead for the Spectrum Dynamics Electrophysiology application, providing non-invasive Functional Imaging for Electrophysiologists utilizing the proprietary SPECT CZT imaging gamma camera technology of Spectrum Dynamics. -
CeoSwat Medical Ab Jan 2014 - Jun 2017Helsingborg, SwedenEnabling superior delivery precision and embolic protection in TAVI and other Cardiovascular Interventions through the patented SWAT™ technology. I was leading the company through the first couple of phases in product development and validation, as well as attracting public and venture capital.
-
Advisor Cardiology Nordic MarketsItamar Medical Dec 2014 - May 2017IsraelA diagnostic solution for Obstructive Sleep Apnea providing a better outcome of arrhythmia treatment, focused on atrial fibrillation. I was opening doors to Key Opinion Leaders and Early Adopters within the clinical field of cardiac arrhythmias and engaged them in programs and studies to better treat patients suffering from arrhythmias and sleep apnea. -
Board MemberPersonal Medsystems Gmbh Nov 2013 - Jan 2017Frankfurt Am Main Area, GermanyAs part of the Board of Directors we turned the company from a pure Medtech company with a traditional sales model into a modern service company with a SaaS business model enables using digital marketing.
-
Business Advisor Life ScienceTeknopol Ab Apr 2013 - Jan 2014Lund, SwedenAs Business Advisors at Teknopol I offered entrepreneurs coaching on how to build a business around a great idea or innovation and turn it into a scalable business. -
Strategic Expansion Arrhythmia LineGlobal Health Partner Ab Jul 2011 - Feb 2012Gotheburg, SwedenI assessed the market for and establishing new high specialist private arrhythmia clinics in Europe in the context of reimbursement landscape, professional skill levels, market opportunity and legal and regulatory preconditions.
-
Vice President Af SolutionsStereotaxis Nov 2010 - Dec 2011Promoted to spearhead comprehensive product development roadmap for a $55MM designer, manufacturer, and marketer of cardiology and cardiovascular robotic system used to treat arrhythmias and coronary artery disease in the U.S. and internationally. Lead global cross-functional team responsible for R&D, clinical affairs, marketing, and regulatory affairs. * Met aggressive proposal deadline for creating full product development roadmap that was presented and accepted by executive leadership team without changes. * Led team in creating roadmap that spanned beyond initial scope of 6-12 months to include 6-24 months. * Roadmap included company’s key products, robotic system, networked workstation, and information backbone solution for Interventional Cardiovascular labs.* Formulated roadmap based on voice of customer, OEM manufacturing partnerships, internal development capabilities, regulator pathways for U.S. and Europe, and available budget.* Devised entrepreneurial and new process for creating development roadmap. Took into account customer input, partners’ capabilities, costs, and timelines. * Model and process is now being applied to similar development projects in sister company. -
General Manager EmeaStereotaxis Mar 2008 - Dec 2010I had full P&L accountability for the EMEA business with combination of direct and distributor operations. Drove evidence-based selling and marketing activities to create new market space in EMEA for novel robotic technology in Interventional Cardiology. Managed 23-person team (capital sales, clinical adoption, administration, training, clinical engineering, technical service). * Grew total EMEA revenue 104% from US$10.3MM to US$21MM in 1 year.* Increased install base of robotic system 30% annually from 27 to 52 and utilization of robotic system 25% annually from 2700 to 4300 procedures.* Introduced robotic technology to new markets, including Sweden, Finland, and South Africa.* Increased global technical service revenues 56% by implementing outside U.S. business agreement with partner company.* Established 2 new global Reference Centers in Europe for capital site visits and clinical adoption training (both in use today by EMEA region and Asia Pacific Region).* Developed, expanded and aligned organizational capabilities to selling innovative and disruptive technologies based on processes and clinical evidence.
-
Vice President EmeaBiosense Webster Sep 2005 - Feb 2008Full P&L accountability for sales and marketing operations in direct countries of Europe – Germany, France, UK, Italy, and Benelux. Led direct field sales/marketing organization of 115 employees in direct (US$115MM in sales) and 85 employees in indirect sales (US$80MM) sales in EMEA. Oversaw marketing, clinical and regulatory affairs, technical service, and market development operations in EMEA headquarters in Waterloo, Belgium. * Ignited sales growth 30% year over year from 2005-2007. Expanded operations in East Europe via direct headcount resources and market subsidiaries.* Revamped sales strategies from product to procedure penetration based and implemented a novel Therapy Expansion marketing strategy across all countries and regions in EMEA via direct and/or indirect sales organization.* Established new sales and marketing division to manage introduction and distribution of new partner technology.* Optimized organizational structure while executing cost/headcount reduction of 9% to meet company’s income target. -
Franchise DirectorCordis Jan 2003 - Sep 2005I directed sales and marketing of Cordis and Biosense Webster cardiovascular products in Sweden, Denmark, Norway, Finland, and Baltic States. Led 4 areas of MSEK330MM cardiovascular business (Cordis Cardiology, Cordis Endovascular, Cordis Neurovascular, Biosense Webster) with full P&L accountability. I managed a team of 25 through 6 direct reports. Member of Managing Board of Johnson & Johnson AB. Reported to CEO of Johnson & Johnson AB.* Doubled Cordis Cardiology Stent business to MSEK160MM in 2 years.* Created new market for new and innovative drug eluting stent technology for treatment of cardiac coronary vascular diseases. * Drove market preparation through financial reimbursement modeling in key markets and gaining support from European and Nordic key opinion leaders. Sold value of life transforming technology of drug eluting coronary stents through clinical data and evidence based selling.* Developed/implemented new sales model with premium pricing (200% above established stents) and created training program for employees and customers. -
Director, Market Development, Emea / Director, Clinical Development, EmeaBiosense Webster Mar 2001 - Jan 2003In this role I drove 40%+ year over year growth reaching total of US$25MM in sales in East Europe countries, Russia, Middle East and Africa. Created national and regional growth strategies for the Biosense Webster business in collaboration with local J&J country management. I developed new novel e-learning based training series for external/internal customer in collaboration with training/marketing departments and worldwide key opinion leaders. Achieved CME accreditation in 2002.
-
Business Unit Manager, Nordic Region / Sales & Clinical Support SpecialistBiosense Webster Sep 1997 - Mar 2001I drove 30% sales growth to SEK40MM via rapid penetration of novel technology for 3D mapping of heart rhythm disturbance. Managed 3 direct reports. As Sales Specialist, advanced sales of new 3-D diagnostic and therapeutic system for interventional electrophysiology and premium-priced disposable products. Increased penetration from 10% to 60% in 3 years covering 80% of major electrophysiology centers in Nordic region. Received Top 3 sales award in 1998 in Nordic Region.
Magnus Holm Skills
Entrepreneurship
Interventional Cardiology
Electrophysiology
Capital Equipment
Venture Capital
P&l Management
Cardiac
Medical Devices
Sales Management
New Business Development
Market Development
Healthcare
Business Strategy
Cross Functional Team Leadership
Leadership Development
Vascular
Strategy
Cardiology
Product Launch
Atrial Fibrillation
Cardiac Rhythm Management
3d Mapping
Cardiac Electrophysiology
Start Ups
Clinical Research
Biomedical Engineering
Lifesciences
Management
Global Marketing
Strategic Partnerships
Commercialization
Product Development
Clinical Development
Business Development
Medical Imaging
Iso 13485
Biotechnology
Hospitals
Fda
Hardware Diagnostics
Life Sciences
Magnus Holm Education Details
-
Clinical Electrophysiology -
Biomedical Engineering
Frequently Asked Questions about Magnus Holm
What company does Magnus Holm work for?
Magnus Holm works for European Commission
What is Magnus Holm's role at the current company?
Magnus Holm's current role is Horizon Europe EIC Accelerator and Transition program jury.
What is Magnus Holm's email address?
Magnus Holm's email address is cl****@****lia.com
What is Magnus Holm's direct phone number?
Magnus Holm's direct phone number is +49305900*****
What schools did Magnus Holm attend?
Magnus Holm attended Lund University, Linköping University.
What skills is Magnus Holm known for?
Magnus Holm has skills like Entrepreneurship, Interventional Cardiology, Electrophysiology, Capital Equipment, Venture Capital, P&l Management, Cardiac, Medical Devices, Sales Management, New Business Development, Market Development, Healthcare.
Who are Magnus Holm's colleagues?
Magnus Holm's colleagues are Jeff Atkins, Anna Sole Mena, Antonio Loredan, Kasia Karcz-Duquesne, Marie Ange Balbinot, Michele Crimella, Sabine Germe.
Not the Magnus Holm you were looking for?
-
1his.se -
Magnus Holm
Örnsköldsviks Kommun -
Magnus Holm
Gothenburg2aclcargo.com, lumenradio.com -
3glorydaysgrill.com, ikstockholm.com, gmail.com
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial